Duncan Clayton H. 4
4 · HEALTHTRONICS, INC. · Filed Jul 7, 2010
Insider Transaction Report
Form 4
Duncan Clayton H.
VP of Radiation Therapy
Transactions
- Tax Payment
Common Stock
2010-07-02$4.85/sh−79,407$385,124→ 318,792 total - Disposition from Tender
Common Stock
2010-07-02$4.85/sh−30,593$148,376→ 288,199 total - Disposition from Tender
Common Stock
2010-07-02$4.85/sh−154,432$748,995→ 77,916 total - Exercise/Conversion
Option to Purchase Common Stock
2010-07-02$4.25/sh−35,000$148,750→ 0 totalExercise: $4.25From: 2010-07-02Exp: 2017-08-22→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2010-07-02$4.25/sh+35,000$148,750→ 323,199 total - Tax Payment
Common Stock
2010-07-02$4.83/sh−55,851$269,760→ 232,348 total - Disposition from Tender
Common Stock
2010-07-02$4.85/sh−77,916$377,893→ 0 total - Exercise/Conversion
Option to Purchase Common Stock
2010-07-02$2.44/sh−75,000$183,000→ 0 totalExercise: $2.44From: 2010-07-02Exp: 2019-11-05→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2010-07-02$2.44/sh+75,000$183,000→ 398,199 total
Footnotes (2)
- [F1]The reporting person's restricted stock awards for 210,283 shares fully vested in connection with the consummation of the tender offer ("the Offer") by Endo Pharmaceuticals Holdings Inc. to acquire all outstanding common stock of HealthTronics, Inc. for $4.85 per share. The Offer closed on July 2, 2010.
- [F2]The reporting person's stock options fully vested in connection with the consummation of the Offer.